Mutated mtDNA acts as a molecular target for therapeutic treatments of age related diseases
University of Cologne - 16-Dec-2022Targeting and eliminating mutated mtDNA by subjecting it to autophagy with rapamycin been successful
Join the club for FREE to access the whole archive and other member benefits.
Postdoc Researcher at University of Cologne
David Pla-Martín is an academic researcher from University of Cologne. The author has contributed to research in topic(s): Mitochondrion & Mitochondrial fission. The author has an hindex of 10, co-authored 16 publication(s) receiving 446 citation(s). Previous affiliations of David Pla-Martín include Spanish National Research Council.
His research is based on understanding how mitochondria and their components, specifically mtDNA, are targeted and eliminated when harboring mutations. Deciphering the specific pathways involved in mtDNA turnover has multiple potential benefits not only against human mtDNA related diseases, but also against normal ageing-related diseases.
Visit website: https://www.cmmc-uni-koeln.de/research/cmmc-researchers/david-pla-martin-curriculum-vitae
See also: University of Cologne - University in Cologne, Germany.
Details last updated 15-Mar-2023
Targeting and eliminating mutated mtDNA by subjecting it to autophagy with rapamycin been successful